UA97240U - Pharmaceutical composition with hemostatic effect - Google Patents

Pharmaceutical composition with hemostatic effect

Info

Publication number
UA97240U
UA97240U UAU201407929U UAU201407929U UA97240U UA 97240 U UA97240 U UA 97240U UA U201407929 U UAU201407929 U UA U201407929U UA U201407929 U UAU201407929 U UA U201407929U UA 97240 U UA97240 U UA 97240U
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
hemostatic effect
amount
swellable polymer
carbopol
Prior art date
Application number
UAU201407929U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Артур Вікторович Мартинов
Олександр Олексійович Богатирьов
Дмитро Олександрович Манич
Original Assignee
Артур Вікторович Мартинов
Олександр Олексійович Богатирьов
Дмитро Олександрович Манич
Державна Установа "Інститут Мікробіології Та Імунології Ім. І.І. Мечникова Намн України"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Артур Вікторович Мартинов, Олександр Олексійович Богатирьов, Дмитро Олександрович Манич, Державна Установа "Інститут Мікробіології Та Імунології Ім. І.І. Мечникова Намн України" filed Critical Артур Вікторович Мартинов
Priority to UAU201407929U priority Critical patent/UA97240U/en
Publication of UA97240U publication Critical patent/UA97240U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A pharmaceutical composition in powder form for local application to the wound to control hemostasis comprises swellable polymer as a main active ingredient. Carbopol dry in an amount of from 50 to 90% as a salt with an amino acid in an amount of from 0.1% to 30%. is used as swellable polymer.
UAU201407929U 2014-07-14 2014-07-14 Pharmaceutical composition with hemostatic effect UA97240U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201407929U UA97240U (en) 2014-07-14 2014-07-14 Pharmaceutical composition with hemostatic effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201407929U UA97240U (en) 2014-07-14 2014-07-14 Pharmaceutical composition with hemostatic effect

Publications (1)

Publication Number Publication Date
UA97240U true UA97240U (en) 2015-03-10

Family

ID=52990403

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201407929U UA97240U (en) 2014-07-14 2014-07-14 Pharmaceutical composition with hemostatic effect

Country Status (1)

Country Link
UA (1) UA97240U (en)

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
CL2016000882A1 (en) Compositions of arni against component c5 of the complement and methods for its use (divisional sol. No. 2710-15).
EA201591004A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
PH12015502013A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
MY191332A (en) Pharmaceutical composition of s-ketamine hydrochloride
EP3116859A4 (en) Novel compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
PE20150199A1 (en) PHARMACEUTICAL COMPOSITIONS AND TREATMENT OF MASTITIS
MX2016014911A (en) Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof.
MX2016011290A (en) Lipoic acid choline ester compositions and methods of use.
WO2016046260A8 (en) 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
BR112017011476A2 (en) amino acid-based composition for fibroelastine recovery in dermal connective tissues and use
EP3606570A4 (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof
AU2016204294A1 (en) Solid State Forms Of A Quinazoline Derivative And Its Use As A BRAF Inhibitor
MX2018004304A (en) Quinoxaline and pyridopyrazine derivatives as pi3kbeta inhibitors.
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
PH12016502386B1 (en) Oral care compositions
MX355668B (en) Use of a myrtle extract as an anti-biofilm agent against p. acnes.
EP3313380A4 (en) Composition for delivery of active agents to an animal
WO2014166836A8 (en) Growth hormone compound formulation
PH12019500024A1 (en) Pharmaceutical compositions
WO2014165513A3 (en) Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof